Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+

This study has been completed.
Information provided by:
The Ojai Foundation Identifier:
First received: August 2, 2010
Last updated: NA
Last verified: August 2010
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)